Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nortriptyline + propranolol is a combination medication used primarily for the prevention of migraine headaches. Nortriptyline is a tricyclic antidepressant that inhibits the reuptake of serotonin and norepinephrine at neuronal cell membranes and blocks pain signal transmission. Propranolol is a beta blocker that slows heart rate and widens blood vessels. Clinical studies have shown that this combination is effective for migraine prevention, with safety profiles similar to monotherapy with either drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nortriptyline + propranolol.